Total Value in 2019: $214,330.91M (166 deals)

Principal company Partner company Value ($M) Technologies Date

November

Abac Therapeutics Tibidabo Ventures Payment unspecified Small molecule therapeutic; intravenous formulation 11/20/19
Avedro Inc. Glaukos Corp. Payment unspecified Ophthalmic liquid formulation; medical device deal; ophthalmic formulation; solution 11/21/19
Biovectra DCL H.I.G. Capital $250.00 Small molecule therapeutic; service laboratory deal 11/4/19
Calporta Therapeutics Inc. Merck & Co Inc. $576.00 Small molecule therapeutic 11/13/19
Celgene Corp. Bristol-Myers Squibb Co. $74,000 Small molecule therapeutic; antibody fragment; biological therapeutic; capsule formulation; chimeric antigen receptor T cell therapy 11/20/19
Dova Pharmaceuticals Inc. Swedish Orphan Biovitrum AB $915.00 Small molecule therapeutic; oral formulation; tablet formulation 11/12/19
Microchips Biotech Inc. Dare Bioscience Inc. $101.50 Drug delivery device deal; implantable device deal 11/20/19
Pointr Data Inc. Mateon Therapeutics Inc. $30.00 Digital health software deal; immuno-oncology 11/4/19
Rodin Therapeutics Inc. Alkermes plc $950.00 Small molecule therapeutic; capsule formulation; oral formulation 11/25/19
Vaxinia Ltd. Imugene Ltd. $2.08 Small molecule therapeutic 11/18/19
Zimmerman Biopharmaceuticals 665 Energy Inc. Payment unspecified Biosimilar product 11/21/19

No Comments